Major Lateral Sclerosis (PLS) is a motor neuron dysfunction characterised by a pure UMN degeneration in bulbar and spinal areas. The important thing distinction with Amyotrophic Lateral Sclerosis (ALS) is the decrease motor neuron system integrity. Regardless of essential literature on this illness, pathophysiology of PLS stays unknown and the hyperlink with ALS nonetheless balances between a continuum and a separate entity to ALS.
We report 9 households through which each PLS and ALS circumstances occurred, generally amongst 1st diploma family members. The sufferers with PLS and ALS had a typical illness presentation. Genetic research revealed mutations in SQSMT1, TBK1 and TREM2 genes in 2 totally different PLS and one ALS sufferers. These outcomes strongly help a phenotypic continuum between PLS and ALS.
Reply to Weisman et al. on: “Effectiveness of allopurinol on lowering mortality: Time-related biases in statemental research”. Arthritis Rheumatol 2021
We thank Weisman et al for his or her letter concerning our assessment of the observational research reporting on the effectiveness of allopurinol on lowering mortality, notably the research affected by immeasurable time bias.1,2 Certainly, our assessment defined that immeasurable time bias might be an essential complexity in observational research the place the end result is dying and hospitalisations are frequent.3.
Small junction, massive issues: Neuromuscular junction pathology in mouse fashions of amyotrophic lateral sclerosis (ALS)
Amyotrophic lateral sclerosis (ALS) is a motor neuron illness with an especially heterogeneous medical and genetic phenotype. In our efforts to seek out therapies for ALS, the scientific group has developed a plethora of mouse fashions, every with their very own advantages and disadvantages. The peripheral nervous system, particularly the neuromuscular junction (NMJ), is understood to be affected in ALS sufferers and exhibits marked dysfunction throughout mouse fashions. Proof of pathology on the NMJ contains denervated NMJs, adjustments in endplate dimension and lack of terminal Schwann cells.
This assessment compares the temporal illness development with severity of illness on the NMJ in mouse fashions with essentially the most generally mutated genes in ALS sufferers (SOD1, C9ORF72, TARDBP and FUS). Regardless of variability, early NMJ dysfunction appears to be a typical consider fashions with SOD1, TARDBP and FUS mutations, whereas C9ORF72 fashions don’t seem to comply with the identical sample of pathology. Additional work into figuring out the timing of NMJ pathology, notably in newer ALS mouse fashions, will affirm its pivotal position in ALS pathogenesis and due to this fact spotlight the NMJ as a possible therapeutic goal.
Residential publicity to electromagnetic fields and threat of amyotrophic lateral sclerosis: a dose-response meta-analysis
Amyotrophic lateral sclerosis (ALS) is neurodegenerative illness characterised by a deadly prognosis and nonetheless unknown etiology. Some environmental threat components have been recommended, together with publicity to magnetic fields. Research have recommended constructive associations in occupationally-exposed populations, however the hyperlink with residential publicity continues to be debated as is the form of such relation. Because of latest availability of superior biostatistical instruments for dose-response meta-analysis, we carried out a scientific assessment with the intention to assess the dose-response affiliation between ALS and residential publicity to magnetic fields.
We carried out a web-based literature looking by means of April 30, 2021. Research had been included in the event that they assessed residential publicity to electromagnetic fields, based mostly both on distance from overhead energy traces or on magnetic discipline modelling methods, and in the event that they reported threat estimates for ALS. We recognized six eligible research, 4 utilizing distance-based and one modelling-based publicity evaluation, and one each strategies.
Each distance-based and notably modelling-based publicity estimates gave the impression to be related to a decreased ALS threat within the highest publicity class, though estimates had been very imprecise (abstract RRs 0.87, 95% CI 0.63-1.20, and 0.27, 95% CI 0.05-1.36). Dose-response meta-analysis additionally confirmed little affiliation between distance from energy traces and ALS, with no proof of any threshold. Total, we discovered scant proof of a constructive affiliation between residential magnetic fields publicity and ALS, though the obtainable knowledge had been too restricted to conduct a dose-response evaluation for the modelled magnetic discipline estimates or to carry out stratified analyses.
Decrease and higher motor neuron involvement and their impression on illness prognosis in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a deadly neurodegenerative illness characterised by progressive muscle losing, respiratory and swallowing difficulties leading to affected person’s dying in two to 5 years after illness onset. In amyotrophic lateral sclerosis, each higher and decrease motor neurons of the corticospinal tracts are concerned within the technique of neurodegeneration, accounting for nice medical heterogeneity of the illness. Scientific phenotype has nice impression on the sample and charge of amyotrophic lateral sclerosis development and total survival prognosis.
Creating extra homogenous affected person teams with the intention to research the consequences of drug brokers on particular manifestations of the illness is a difficult situation in amyotrophic lateral sclerosis medical trials. Since amyotrophic lateral sclerosis has low incidence charges, conduction of multicenter trials requires sure standardized approaches to illness prognosis and staging.
This assessment focuses on the present approaches in amyotrophic lateral sclerosis classification and staging system based mostly on medical examination and extra instrumental strategies, highlighting the position of higher and decrease motor neuron involvement in several phenotypes of the illness. We exhibit that each medical and instrumental findings might be helpful in evaluating severity of higher motor neuron and decrease motor neuron involvement and predicting the next course of the illness.
 (PE)) ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (PE) |
|
MBS6156491-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (PE) |
|
MBS6156491-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
 (AP)) ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (AP) |
|
MBS6129976-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (AP) |
|
MBS6129976-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
 APC) ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) APC |
|
MBS6135279-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) APC |
|
MBS6135279-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (AP) |
|
MBS6369693-01mL |
MyBiosource |
0.1mL |
EUR 920 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (AP) |
|
MBS6369693-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) APC |
|
MBS6369694-01mL |
MyBiosource |
0.1mL |
EUR 920 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) APC |
|
MBS6369694-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
 (Biotin)) ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (Biotin) |
|
MBS6369695-01mL |
MyBiosource |
0.1mL |
EUR 920 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (Biotin) |
|
MBS6369695-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
 (FITC)) ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (FITC) |
|
MBS6369696-01mL |
MyBiosource |
0.1mL |
EUR 920 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (FITC) |
|
MBS6369696-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
 (HRP)) ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (HRP) |
|
MBS6369697-01mL |
MyBiosource |
0.1mL |
EUR 920 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (HRP) |
|
MBS6369697-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (PE) |
|
MBS6369703-01mL |
MyBiosource |
0.1mL |
EUR 920 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (PE) |
|
MBS6369703-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
) ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) |
|
MBS641128-02mL |
MyBiosource |
0.2mL |
EUR 695 |
ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) |
|
MBS641128-5x02mL |
MyBiosource |
5x0.2mL |
EUR 2975 |
) Alsin, CT (ALS2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, Amyotrophic Lateral Sclerosis 2 Protein, ALS2CR6, KIAA1563) |
|
MBS649300-005mg |
MyBiosource |
0.05mg |
EUR 745 |
Alsin, CT (ALS2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, Amyotrophic Lateral Sclerosis 2 Protein, ALS2CR6, KIAA1563) |
|
MBS649300-5x005mg |
MyBiosource |
5x0.05mg |
EUR 3195 |
 (AP)) ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (AP) |
|
MBS6462568-02mL |
MyBiosource |
0.2mL |
EUR 980 |
ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (AP) |
|
MBS6462568-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (APC)) ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (APC) |
|
MBS6462569-02mL |
MyBiosource |
0.2mL |
EUR 980 |
ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (APC) |
|
MBS6462569-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (Biotin)) ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (Biotin) |
|
MBS6462570-02mL |
MyBiosource |
0.2mL |
EUR 980 |
ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (Biotin) |
|
MBS6462570-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (FITC)) ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (FITC) |
|
MBS6462571-02mL |
MyBiosource |
0.2mL |
EUR 980 |
ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (FITC) |
|
MBS6462571-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (HRP)) ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (HRP) |
|
MBS6462572-02mL |
MyBiosource |
0.2mL |
EUR 980 |
ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (HRP) |
|
MBS6462572-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (PE)) ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (PE) |
|
MBS6462578-02mL |
MyBiosource |
0.2mL |
EUR 980 |
ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (PE) |
|
MBS6462578-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (MaxLight 650)) ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 650) |
|
MBS6220864-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 650) |
|
MBS6220864-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
 (MaxLight 750)) ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 750) |
|
MBS6231539-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 750) |
|
MBS6231539-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
 (MaxLight 490)) ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 490) |
|
MBS6199514-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 490) |
|
MBS6199514-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
 (MaxLight 405)) ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 405) |
|
MBS6188839-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 405) |
|
MBS6188839-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
 (MaxLight 550)) ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 550) |
|
MBS6210189-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 550) |
|
MBS6210189-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 405) |
|
MBS6369698-01mL |
MyBiosource |
0.1mL |
EUR 920 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 405) |
|
MBS6369698-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 490) |
|
MBS6369699-01mL |
MyBiosource |
0.1mL |
EUR 920 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 490) |
|
MBS6369699-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 550) |
|
MBS6369700-01mL |
MyBiosource |
0.1mL |
EUR 920 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 550) |
|
MBS6369700-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 650) |
|
MBS6369701-01mL |
MyBiosource |
0.1mL |
EUR 920 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 650) |
|
MBS6369701-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 750) |
|
MBS6369702-01mL |
MyBiosource |
0.1mL |
EUR 920 |
ALS2 (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 750) |
|
MBS6369702-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
) Human iPS Cell Line (Amyotrophic Lateral Sclerosis) |
|
CSC-00848L |
Creative Bioarray |
One Frozen vial |
Ask for price |
|
|
 (MaxLight 405)) ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 405) |
|
MBS6462573-01mL |
MyBiosource |
0.1mL |
EUR 980 |
ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 405) |
|
MBS6462573-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 490)) ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 490) |
|
MBS6462574-01mL |
MyBiosource |
0.1mL |
EUR 980 |
ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 490) |
|
MBS6462574-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 550)) ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 550) |
|
MBS6462575-01mL |
MyBiosource |
0.1mL |
EUR 980 |
ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 550) |
|
MBS6462575-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 650)) ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 650) |
|
MBS6462576-01mL |
MyBiosource |
0.1mL |
EUR 980 |
ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 650) |
|
MBS6462576-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 750)) ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 750) |
|
MBS6462577-01mL |
MyBiosource |
0.1mL |
EUR 980 |
ALS2, CT (Alsin, Amyotrophic Lateral Sclerosis Protein 2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 6 Protein, KIAA1563, ALS2CR6) (MaxLight 750) |
|
MBS6462577-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
) HighQC™ Human IPS Cell (Amyotrophic Lateral Sclerosis) |
|
ABC-SC0002T |
AcceGen |
1 vial |
Ask for price |
|
Description: Induced Pluriopotent Stem Cells (iPSCs) are a type of pluripotent stem cells that can be derived directly from adult somatic cells . The derived iPSCs can propagate indefinitely, as well as give rise to other cell types in the body. iPS cells, thus, hold great promise in the field of regenerative medicine by representing a single source of cells that could be used to replace those damaged/diseased cells. |
 Antibody) Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody |
|
abx338368-100g |
Abbexa |
100 µg |
EUR 162.5 |
Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody |
|
20-abx338368 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
 - Rat amyotrophic lateral sclerosis 2 (juvenile) homolog (human) (Als2), (10 ug)) Als2 (untagged ORF) - Rat amyotrophic lateral sclerosis 2 (juvenile) homolog (human) (Als2), (10 ug) |
|
RN205048 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 Antibody (HRP)) Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody (HRP) |
|
abx334692-100g |
Abbexa |
100 µg |
EUR 362.5 |
Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody (HRP) |
|
20-abx334692 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody (HRP) |
|
abx334692-20g |
Abbexa |
20 µg |
EUR 162.5 |
Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody (HRP) |
|
abx334692-50g |
Abbexa |
50 µg |
EUR 250 |
 Antibody (FITC)) Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody (FITC) |
|
abx334693-100g |
Abbexa |
100 µg |
EUR 362.5 |
Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody (FITC) |
|
20-abx334693 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody (FITC) |
|
abx334693-20g |
Abbexa |
20 µg |
EUR 162.5 |
Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody (FITC) |
|
abx334693-50g |
Abbexa |
50 µg |
EUR 250 |
 Antibody (Biotin)) Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody (Biotin) |
|
abx334694-100g |
Abbexa |
100 µg |
EUR 362.5 |
Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody (Biotin) |
|
20-abx334694 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody (Biotin) |
|
abx334694-20g |
Abbexa |
20 µg |
EUR 162.5 |
Amyotrophic Lateral Sclerosis 2 Chromosome Region 12 (ALS2CR12) Antibody (Biotin) |
|
abx334694-50g |
Abbexa |
50 µg |
EUR 250 |
 Chromosome Region,candidate 2)) ALS2CR2 (Amyotrophic Lateral Sclerosis 2 (juvenile) Chromosome Region,candidate 2) |
|
MBS615164-005mg |
MyBiosource |
0.05mg |
EUR 745 |
ALS2CR2 (Amyotrophic Lateral Sclerosis 2 (juvenile) Chromosome Region,candidate 2) |
|
MBS615164-5x005mg |
MyBiosource |
5x0.05mg |
EUR 3195 |
 - Mouse amyotrophic lateral sclerosis 2 (juvenile) homolog (human) (Als2)) Als2 (GFP-tagged) - Mouse amyotrophic lateral sclerosis 2 (juvenile) homolog (human) (Als2) |
|
MG212062 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Rat amyotrophic lateral sclerosis 2 (juvenile) homolog (human) (Als2), (10 ug)) Als2 (Myc-DDK-tagged ORF) - Rat amyotrophic lateral sclerosis 2 (juvenile) homolog (human) (Als2), (10 ug) |
|
RR205048 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 (AP)) SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (AP) |
|
MBS6438530-01mL |
MyBiosource |
0.1mL |
EUR 960 |
SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (AP) |
|
MBS6438530-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4160 |
 (APC)) SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (APC) |
|
MBS6438531-01mL |
MyBiosource |
0.1mL |
EUR 960 |
SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (APC) |
|
MBS6438531-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4160 |
 (HRP)) SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (HRP) |
|
MBS6438534-01mL |
MyBiosource |
0.1mL |
EUR 960 |
SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (HRP) |
|
MBS6438534-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4160 |
 (PE)) SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (PE) |
|
MBS6438540-01mL |
MyBiosource |
0.1mL |
EUR 960 |
SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (PE) |
|
MBS6438540-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4160 |
-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 2) ALS2 (untagged)-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 2 |
|
SC325876 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 1) ALS2 (untagged)-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 1 |
|
SC308723 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 ELISA Kit) Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein (ALS2CR12) ELISA Kit |
|
MBS7216080-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5685 |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein (ALS2CR12) ELISA Kit |
|
MBS7216080-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 485 |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein (ALS2CR12) ELISA Kit |
|
MBS7216080-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3020 |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein (ALS2CR12) ELISA Kit |
|
MBS7216080-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 690 |
 ELISA Kit) Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein (ALS2CR11) ELISA Kit |
|
MBS7215191-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5685 |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein (ALS2CR11) ELISA Kit |
|
MBS7215191-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 485 |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein (ALS2CR11) ELISA Kit |
|
MBS7215191-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3020 |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein (ALS2CR11) ELISA Kit |
|
MBS7215191-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 690 |
 ELISA kit) Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein(ALS2CR11) ELISA kit |
|
E02A1410-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein(ALS2CR11) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein(ALS2CR11) ELISA kit |
|
E02A1410-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein(ALS2CR11) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein(ALS2CR11) ELISA kit |
|
E02A1410-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein(ALS2CR11) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
 ELISA kit) Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein(ALS2CR12) ELISA kit |
|
E02A1411-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein(ALS2CR12) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein(ALS2CR12) ELISA kit |
|
E02A1411-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein(ALS2CR12) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein(ALS2CR12) ELISA kit |
|
E02A1411-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein(ALS2CR12) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
 ELISA kit) Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein(ALS2CR8) ELISA kit |
|
E02A1412-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein(ALS2CR8) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein(ALS2CR8) ELISA kit |
|
E02A1412-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein(ALS2CR8) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein(ALS2CR8) ELISA kit |
|
E02A1412-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A sandwich ELISA for quantitative measurement of Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein(ALS2CR8) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein(ALS2CR11) ELISA kit |
|
E01A9589 |
BlueGene |
96T |
EUR 700 |
|
Description: ELISA |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein(ALS2CR12) ELISA kit |
|
E01A9590 |
BlueGene |
96T |
EUR 700 |
|
Description: ELISA |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein(ALS2CR8) ELISA kit |
|
E01A9591 |
BlueGene |
96T |
EUR 700 |
|
Description: ELISA |
 ELISA Kit) Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein (ALS2CR8) ELISA Kit |
|
MBS7251476-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5685 |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein (ALS2CR8) ELISA Kit |
|
MBS7251476-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 485 |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein (ALS2CR8) ELISA Kit |
|
MBS7251476-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3020 |
Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein (ALS2CR8) ELISA Kit |
|
MBS7251476-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 690 |
 HighQC™ Induced Pluripotent Stem Cell, From Amyotrophic Lateral Sclerosis |
|
ABC-SC0211 |
AcceGen |
1 vial |
Ask for price |
|
Description: Amyotrophic Lateral Sclerosis donor, Derived from fibroblast, Passage number reprogrammed: 4, Passage Number: 26; Cells are only guaranteed with purchase of Gentaur Media and Gentaur Extra Cellular Matrix for appropriate cell culture, for 30 days from the date of shipment. |
 - Rat amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11 (Als2cr11)) Als2cr11 (untagged) - Rat amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11 (Als2cr11) |
|
RN216914 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 (Biotin)) SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (Biotin) |
|
MBS6438532-01mL |
MyBiosource |
0.1mL |
EUR 960 |
SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (Biotin) |
|
MBS6438532-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4160 |
 (FITC)) SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (FITC) |
|
MBS6438533-01mL |
MyBiosource |
0.1mL |
EUR 960 |
SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (FITC) |
|
MBS6438533-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4160 |
 - Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 1) ALS2 (GFP-tagged) - Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 1 |
|
RG215448 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 2) ALS2 (GFP-tagged) - Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 2 |
|
RG226660 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 Antibody) Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 1 Protein (ALS2CR1) Antibody |
|
abx430786-200l |
Abbexa |
200 µl |
EUR 387.5 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 1 Protein (ALS2CR1) Antibody |
|
abx430786-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
|
 Antibody) Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 2 Protein (ALS2CR2) Antibody |
|
abx430794-200l |
Abbexa |
200 µl |
EUR 387.5 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 2 Protein (ALS2CR2) Antibody |
|
abx430794-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
|
 Antibody) Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 3 Protein (ALS2CR3) Antibody |
|
abx430795-200l |
Abbexa |
200 µl |
EUR 387.5 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 3 Protein (ALS2CR3) Antibody |
|
abx430795-200ul |
Abbexa |
200 ul |
EUR 343.2 |
|
|
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 3 Protein (ALS2CR3) Antibody |
|
abx037540-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
|
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 3 Protein (ALS2CR3) Antibody |
|
abx037540-96tests |
Abbexa |
96 tests |
EUR 337.5 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 3 Protein (ALS2CR3) Antibody |
|
abx038241-100g |
Abbexa |
100 µg |
EUR 337.5 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 3 Protein (ALS2CR3) Antibody |
|
abx038241-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
|
 Antibody) Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 7 Protein (ALS2CR7) Antibody |
|
abx033445-100g |
Abbexa |
100 µg |
EUR 250 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 7 Protein (ALS2CR7) Antibody |
|
abx033445-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 7 Protein (ALS2CR7) Antibody |
|
abx033445-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
 Antibody) Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 4 Protein (ALS2CR4) Antibody |
|
abx014186-100g |
Abbexa |
100 µg |
EUR 43.75 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 4 Protein (ALS2CR4) Antibody |
|
20-abx014186 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 100 ug
- 200 ug
- 300 µg
|
|
|
 Antibody) Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 8 Protein (ALS2CR8) Antibody |
|
abx014187-100g |
Abbexa |
100 µg |
EUR 43.75 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 8 Protein (ALS2CR8) Antibody |
|
20-abx014187 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 100 ug
- 200 ug
- 300 µg
|
|
|
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 8 Protein (ALS2CR8) Antibody |
|
abx230351-100g |
Abbexa |
100 µg |
EUR 350 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 8 Protein (ALS2CR8) Antibody |
|
abx230351-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
|
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 2 Protein (ALS2CR2) Antibody |
|
abx122767-100l |
Abbexa |
100 µl |
Ask for price |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 2 Protein (ALS2CR2) Antibody |
|
abx122767-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
|
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 2 Protein (ALS2CR2) Antibody |
|
abx122767-20l |
Abbexa |
20 µl |
EUR 337.5 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 2 Protein (ALS2CR2) Antibody |
|
abx122767-50l |
Abbexa |
50 µl |
Ask for price |
) AL2SA, NT (ALS2CR11, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein) |
|
MBS6012609-02mL |
MyBiosource |
0.2(mL |
EUR 695 |
AL2SA, NT (ALS2CR11, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein) |
|
MBS6012609-5x02mL |
MyBiosource |
5x0.2mL |
EUR 2975 |
, ALS2CR6, ALSJ, FLJ31851, IAHSP, KIAA1563, MGC87187, PLSJ) (AP)) ALS2 (Amyotrophic Lateral Sclerosis 2 (juvenile), ALS2CR6, ALSJ, FLJ31851, IAHSP, KIAA1563, MGC87187, PLSJ) (AP) |
|
MBS6164583-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
ALS2 (Amyotrophic Lateral Sclerosis 2 (juvenile), ALS2CR6, ALSJ, FLJ31851, IAHSP, KIAA1563, MGC87187, PLSJ) (AP) |
|
MBS6164583-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
, ALS2CR6, ALSJ, FLJ31851, IAHSP, KIAA1563, MGC87187, PLSJ) (PE)) ALS2 (Amyotrophic Lateral Sclerosis 2 (juvenile), ALS2CR6, ALSJ, FLJ31851, IAHSP, KIAA1563, MGC87187, PLSJ) (PE) |
|
MBS6186633-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
ALS2 (Amyotrophic Lateral Sclerosis 2 (juvenile), ALS2CR6, ALSJ, FLJ31851, IAHSP, KIAA1563, MGC87187, PLSJ) (PE) |
|
MBS6186633-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
 (MaxLight 405)) SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (MaxLight 405) |
|
MBS6438535-01mL |
MyBiosource |
0.1mL |
EUR 960 |
SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (MaxLight 405) |
|
MBS6438535-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4160 |
 (MaxLight 490)) SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (MaxLight 490) |
|
MBS6438536-01mL |
MyBiosource |
0.1mL |
EUR 960 |
SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (MaxLight 490) |
|
MBS6438536-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4160 |
 (MaxLight 550)) SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (MaxLight 550) |
|
MBS6438537-01mL |
MyBiosource |
0.1mL |
EUR 960 |
SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (MaxLight 550) |
|
MBS6438537-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4160 |
 (MaxLight 650)) SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (MaxLight 650) |
|
MBS6438538-01mL |
MyBiosource |
0.1mL |
EUR 960 |
SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (MaxLight 650) |
|
MBS6438538-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4160 |
 (MaxLight 750)) SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (MaxLight 750) |
|
MBS6438539-01mL |
MyBiosource |
0.1mL |
EUR 960 |
SOD1 (Superoxide Dismutase 1, Superoxide Dismutase, Cu/Zn, Amyotrophic Lateral Sclerosis 1, ALS, ALS1, IPOA, SOD, Homodimer) (MaxLight 750) |
|
MBS6438539-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4160 |
 polyclonal Antibody) Rabbit anti-human amyotrophic lateral sclerosis 2 (juvenile) polyclonal Antibody |
|
MBS712873-01mL |
MyBiosource |
0.1mL |
EUR 485 |
Rabbit anti-human amyotrophic lateral sclerosis 2 (juvenile) polyclonal Antibody |
|
MBS712873-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2175 |
-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 1) ALS2 (Myc-DDK-tagged)-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 1 |
|
RC215448 |
Origene Technologies GmbH |
10 µg |
Ask for price |
-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 2) ALS2 (Myc-DDK-tagged)-Human amyotrophic lateral sclerosis 2 (juvenile) (ALS2), transcript variant 2 |
|
RC226660 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 Antibody) Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 11 Protein (ALS2CR11) Antibody |
|
abx307348-100g |
Abbexa |
100 µg |
EUR 362.5 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 11 Protein (ALS2CR11) Antibody |
|
20-abx307348 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 11 Protein (ALS2CR11) Antibody |
|
abx307348-20g |
Abbexa |
20 µg |
EUR 162.5 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 11 Protein (ALS2CR11) Antibody |
|
abx307348-50g |
Abbexa |
50 µg |
EUR 250 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 11 Protein (ALS2CR11) Antibody |
|
abx014185-100g |
Abbexa |
100 µg |
EUR 43.75 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 11 Protein (ALS2CR11) Antibody |
|
20-abx014185 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 100 ug
- 200 ug
- 300 µg
|
|
|
 Antibody) Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 13 Protein (ALS2CR13) Antibody |
|
abx014188-100g |
Abbexa |
100 µg |
EUR 43.75 |
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 13 Protein (ALS2CR13) Antibody |
|
20-abx014188 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 100 ug
- 200 ug
- 300 µg
|
|
|
 Antibody) Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 12 Protein (ALS2CR12) Antibody |
|
20-abx148158 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
 Antibody) Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 16 Protein (ALS2CR16) Antibody |
|
20-abx148159 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 13 Protein (ALS2CR13) Antibody |
|
20-abx121963 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
|
 (AP)) AL2SA, NT (ALS2CR11, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein) (AP) |
|
MBS6272707-02mL |
MyBiosource |
0.2mL |
EUR 980 |
AL2SA, NT (ALS2CR11, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein) (AP) |
|
MBS6272707-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (APC)) AL2SA, NT (ALS2CR11, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein) (APC) |
|
MBS6272708-02mL |
MyBiosource |
0.2mL |
EUR 980 |
AL2SA, NT (ALS2CR11, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein) (APC) |
|
MBS6272708-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (FITC)) AL2SA, NT (ALS2CR11, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein) (FITC) |
|
MBS6272710-02mL |
MyBiosource |
0.2mL |
EUR 980 |
AL2SA, NT (ALS2CR11, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein) (FITC) |
|
MBS6272710-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (PE)) AL2SA, NT (ALS2CR11, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein) (PE) |
|
MBS6272717-02mL |
MyBiosource |
0.2mL |
EUR 980 |
AL2SA, NT (ALS2CR11, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein) (PE) |
|
MBS6272717-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
) Recombinant Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein homolog (Als2cr12) |
|
MBS1357584-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1285 |
Recombinant Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein homolog (Als2cr12) |
|
MBS1357584-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 960 |
Recombinant Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein homolog (Als2cr12) |
|
MBS1357584-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1075 |
Recombinant Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein homolog (Als2cr12) |
|
MBS1357584-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1120 |
Recombinant Rat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein homolog (Als2cr12) |
|
MBS1357584-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1225 |
 ELISA Kit) Goat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein (ALS2CR8) ELISA Kit |
|
MBS7249220-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5685 |
Goat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein (ALS2CR8) ELISA Kit |
|
MBS7249220-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 485 |
Goat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein (ALS2CR8) ELISA Kit |
|
MBS7249220-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3020 |
Goat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein (ALS2CR8) ELISA Kit |
|
MBS7249220-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 690 |
 ELISA kit) Goat Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein(ALS2CR8) ELISA kit |
|
E01A44510 |
BlueGene |
96T |
EUR 700 |
|
Description: ELISA |
Addressing illness heterogeneity in amyotrophic lateral sclerosis medical trials may result in research designs that may assess drug efficacy in particular affected person teams, based mostly on the illness pathophysiology and spatiotemporal sample. Though medical analysis is usually a enough screening methodology for dividing amyotrophic lateral sclerosis sufferers into medical subgroups, we offer proof that instrumental research may present helpful insights within the illness pathology.
